Race Oncology Limited (RAONF)
USD 1.22
(0.0%)
USD 1.22
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | -7.09 Million | -4.31 Million | -3.52 Million | -1.69 Million | -1.87 Million |
| Net Income | - | -6.6 Million | -7.72 Million | -4.75 Million | -2.64 Million | -2.56 Million |
| Depreciation & Amortization | - | 187.27 Thousand | 194.03 Thousand | 211.1 Thousand | 193.6 Thousand | 197.32 Thousand |
| Deferred income taxes | - | -393.3 Thousand | -2.12 Million | -1.7 Million | -754.52 Thousand | -570.09 Thousand |
| Stock-based compensation | - | 393.3 Thousand | 2.12 Million | 1.7 Million | 754.52 Thousand | 570.09 Thousand |
| Change in working capital | - | -1.11 Million | 1.07 Million | -679.62 Thousand | 2512.34 | -85.1 Thousand |
| Other non-cash items | - | 447.79 Thousand | 2.14 Million | 1.7 Million | 756 Thousand | 579.28 Thousand |
| Investing Cash Flow | - | 5.14 Million | -19.52 Million | 105.39 Thousand | -11.62 Thousand | -133.64 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 5.2 Million | -854.17 Thousand | 21.05 Million | 9.21 Million | 2.21 Million | -23.74 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -4621.00 | -854.17 Thousand | -463.48 Thousand | -510.53 Thousand | -142.06 Thousand | -33.84 Thousand |
| Common Stock Issuance | 5.21 Million | -1.28 Million | 21.05 Million | 9.21 Million | 2.21 Million | -23.74 Thousand |
| Other Financing Activities | - | 1.28 Million | 463.48 Thousand | 510.53 Thousand | 142.06 Thousand | 33.84 Thousand |
| Accounts receivables | - | -1.09 Million | 45.33 Thousand | -59.49 Thousand | -33.25 Thousand | -127.02 |
| Accounts payables | - | -176.85 Thousand | 617.03 Thousand | 209.8 Thousand | 35.47 Thousand | -82.51 Thousand |
| Inventory | - | -1.00 | 1.00 | -1.00 | 0.48 | 0.46 |
| Other working capital | - | 150.18 Thousand | 409.13 Thousand | -829.92 Thousand | 289.86 | -2462.44 |
| Cash at beginning of period | 21.52 Million | 4.16 Million | 6.99 Million | 1.19 Million | 693.82 Thousand | 2.74 Million |
| Cash at end of period | 17.18 Million | 1.27 Million | 4.16 Million | 6.99 Million | 1.19 Million | 693.82 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | 5446.00 | -86.32 Thousand | -38.22 Thousand | 9394.00 | -4730.00 | -13.44 Thousand |
| Net cash flow / Change in cash | -4.33 Million | -2.88 Million | -2.83 Million | 5.8 Million | 497.81 Thousand | -2.04 Million |
| Free Cash Flow | - | -7.09 Million | -4.31 Million | -3.52 Million | -1.69 Million | -1.87 Million |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.43 Million | -3.85 Million | -6.6 Million | -3.67 Million | -3 Million | -7.72 Million |
| Depreciation & Amortization | 93.72 Thousand | 95.71 Thousand | 187.27 Thousand | 93.63 Thousand | 95.8 Thousand | 194.03 Thousand |
| Deferred income taxes | - | - | -393.3 Thousand | - | - | -2.12 Million |
| Stock-based compensation | - | - | 393.3 Thousand | - | - | 2.12 Million |
| Change in working capital | - | - | -1.11 Million | - | - | 1.07 Million |
| Other non-cash items | 4.6 Million | -1.6 Million | 447.79 Thousand | 578.08 Thousand | -895.97 Thousand | 2.14 Million |
| Investing Cash Flow | - | - | 5.14 Million | - | - | -19.52 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 3.25 Million | 218.26 Thousand | -854.17 Thousand | 0.67 | -873.91 Thousand | 21.05 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -854.17 Thousand | 0.67 | -873.91 Thousand | -463.48 Thousand |
| Common Stock Issuance | 3.25 Million | 218.26 Thousand | -1.28 Million | - | - | 21.05 Million |
| Other Financing Activities | - | - | 1.28 Million | - | - | 463.48 Thousand |
| Accounts receivables | - | - | -1.09 Million | - | - | 45.33 Thousand |
| Accounts payables | - | - | -176.85 Thousand | - | - | 617.03 Thousand |
| Inventory | - | - | -1.00 | - | - | 1.00 |
| Other working capital | - | - | 150.18 Thousand | - | - | 409.13 Thousand |
| Cash at beginning of period | 9.33 Million | 1.27 Million | 4.16 Million | 17.97 Million | 4.16 Million | 6.99 Million |
| Cash at end of period | 925.79 Thousand | 9.33 Million | 1.27 Million | 1.27 Million | 17.97 Million | 4.16 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | -86.32 Thousand | - | - | -38.22 Thousand |
| Net cash flow / Change in cash | -8.41 Million | 8.05 Million | -2.88 Million | -16.69 Million | 13.8 Million | -2.83 Million |
| Free Cash Flow | -927.22 Thousand | -5.55 Million | -7.09 Million | -3.18 Million | -3.99 Million | -4.31 Million |
MNTSW
SATX
ALATA
PGIL
SPAL
EEGI